298 related articles for article (PubMed ID: 30318009)
21. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.
Sugimoto K; Suzuki HI; Fujimura T; Ono A; Kaga N; Isobe Y; Sasaki M; Taka H; Miyazono K; Komatsu N
Cancer Sci; 2015 Nov; 106(11):1534-43. PubMed ID: 26331698
[TBL] [Abstract][Full Text] [Related]
22. L-asparaginase production review: bioprocess design and biochemical characteristics.
Castro D; Marques ASC; Almeida MR; de Paiva GB; Bento HBS; Pedrolli DB; Freire MG; Tavares APM; Santos-Ebinuma VC
Appl Microbiol Biotechnol; 2021 Jun; 105(11):4515-4534. PubMed ID: 34059941
[TBL] [Abstract][Full Text] [Related]
23. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
[TBL] [Abstract][Full Text] [Related]
24. Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
Jarrar M; Gaynon PS; Periclou AP; Fu C; Harris RE; Stram D; Altman A; Bostrom B; Breneman J; Steele D; Trigg M; Zipf T; Avramis VI
Pediatr Blood Cancer; 2006 Aug; 47(2):141-6. PubMed ID: 16425271
[TBL] [Abstract][Full Text] [Related]
25. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
Yamada T; Ishimaru M; Shoji T; Tomiyasu H; Tochinai R; Taguchi K; Komatsu T
ACS Appl Bio Mater; 2023 Dec; 6(12):5789-5797. PubMed ID: 38047730
[TBL] [Abstract][Full Text] [Related]
26. Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.
Ko RH; Jones TL; Radvinsky D; Robison N; Gaynon PS; Panosyan EH; Avramis IA; Avramis VI; Rubin J; Ettinger LJ; Seibel NL; Dhall G
Cancer; 2015 Dec; 121(23):4205-11. PubMed ID: 26308766
[TBL] [Abstract][Full Text] [Related]
27. Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).
Grigoryan RS; Panosyan EH; Seibel NL; Gaynon PS; Avramis IA; Avramis VI
In Vivo; 2004; 18(2):107-12. PubMed ID: 15113036
[TBL] [Abstract][Full Text] [Related]
28. A critical analysis of L-asparaginase activity quantification methods-colorimetric methods versus high-performance liquid chromatography.
Magri A; Soler MF; Lopes AM; Cilli EM; Barber PS; Pessoa A; Pereira JFB
Anal Bioanal Chem; 2018 Nov; 410(27):6985-6990. PubMed ID: 30155702
[TBL] [Abstract][Full Text] [Related]
29. Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.
Saeed H; Hemida A; El-Nikhely N; Abdel-Fattah M; Shalaby M; Hussein A; Eldoksh A; Ataya F; Aly N; Labrou N; Nematalla H
Int J Biol Macromol; 2020 Aug; 156():812-828. PubMed ID: 32311402
[TBL] [Abstract][Full Text] [Related]
30. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.
Saeed H; Hemida A; Abdel-Fattah M; Eldoksh A; Shalaby M; Nematalla H; El-Nikhely N; Elkewedi M
Protein Expr Purif; 2021 May; 181():105820. PubMed ID: 33440252
[TBL] [Abstract][Full Text] [Related]
31. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
Kotzia GA; Labrou NE
J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
[TBL] [Abstract][Full Text] [Related]
32. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
[TBL] [Abstract][Full Text] [Related]
33. [Purification and properties of recombinant Erwinia carotovora L-asparaginase expressed in E.coli cells].
Borisova AA; El'darov MA; Zhgun AA; Aleksandrova SS; Omel'ianiuk NM; Sokov BN; Berezov TT; Sokolov NN
Biomed Khim; 2003; 49(5):502-7. PubMed ID: 16119104
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional role of Gly281 in L-asparaginase from Erwinia carotovora.
Kotzia GA; Labrou NE
Protein Pept Lett; 2013 Dec; 20(12):1302-7. PubMed ID: 24261975
[TBL] [Abstract][Full Text] [Related]
35. [PEG-chitosan branched copolymers to improve the biocatalytic properties of Erwinia carotovora recombinant L-asparaginase].
Kudryashova EV; Suhoverkov KV; Sokolov NN
Biomed Khim; 2015; 61(4):480-7. PubMed ID: 26350739
[TBL] [Abstract][Full Text] [Related]
36. Marine microbial L-asparaginase: Biochemistry, molecular approaches and applications in tumor therapy and in food industry.
Izadpanah Qeshmi F; Homaei A; Fernandes P; Javadpour S
Microbiol Res; 2018 Mar; 208():99-112. PubMed ID: 29551216
[TBL] [Abstract][Full Text] [Related]
37. Asparagine concentration in plasma after 2,500 IU/m(2) PEG-asparaginase i.v. in children with acute lymphoblastic leukemia.
Wenner KA; Vieira Pinheiro JP; Escherich G; Wessalowski R; Jorch N; Wolff J; Stehn M; Kohlschütter A; Boos J; Janka-Schaub GE
Klin Padiatr; 2005; 217(6):321-6. PubMed ID: 16307417
[TBL] [Abstract][Full Text] [Related]
38. A Comprehensive Review on L-Asparaginase and Its Applications.
Batool T; Makky EA; Jalal M; Yusoff MM
Appl Biochem Biotechnol; 2016 Mar; 178(5):900-23. PubMed ID: 26547852
[TBL] [Abstract][Full Text] [Related]
39. Microbial L-asparaginase: purification, characterization and applications.
Muneer F; Siddique MH; Azeem F; Rasul I; Muzammil S; Zubair M; Afzal M; Nadeem H
Arch Microbiol; 2020 Jul; 202(5):967-981. PubMed ID: 32052094
[TBL] [Abstract][Full Text] [Related]
40. A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora.
Belén LH; Lissabet JB; de Oliveira Rangel-Yagui C; Effer B; Monteiro G; Pessoa A; Farías Avendaño JG
Biologicals; 2019 May; 59():47-55. PubMed ID: 30871932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]